Cargando…

P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS

Detalles Bibliográficos
Autores principales: Maas, Carolien, van Klaveren, David, Durmaz, Mujde, Visser, Otto, Issa, Djamila, Posthuma, Eduardus F.M., Zijlstra, Josée, Chamuleau, Martine, Lugtenburg, Pieternella, José Kersten, Marie, Dinmohamed, Avinash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431182/
http://dx.doi.org/10.1097/01.HS9.0000971452.80376.cd
_version_ 1785091140801789952
author Maas, Carolien
van Klaveren, David
Durmaz, Mujde
Visser, Otto
Issa, Djamila
Posthuma, Eduardus F.M.
Zijlstra, Josée
Chamuleau, Martine
Lugtenburg, Pieternella
José Kersten, Marie
Dinmohamed, Avinash
author_facet Maas, Carolien
van Klaveren, David
Durmaz, Mujde
Visser, Otto
Issa, Djamila
Posthuma, Eduardus F.M.
Zijlstra, Josée
Chamuleau, Martine
Lugtenburg, Pieternella
José Kersten, Marie
Dinmohamed, Avinash
author_sort Maas, Carolien
collection PubMed
description
format Online
Article
Text
id pubmed-10431182
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311822023-08-17 P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS Maas, Carolien van Klaveren, David Durmaz, Mujde Visser, Otto Issa, Djamila Posthuma, Eduardus F.M. Zijlstra, Josée Chamuleau, Martine Lugtenburg, Pieternella José Kersten, Marie Dinmohamed, Avinash Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431182/ http://dx.doi.org/10.1097/01.HS9.0000971452.80376.cd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Maas, Carolien
van Klaveren, David
Durmaz, Mujde
Visser, Otto
Issa, Djamila
Posthuma, Eduardus F.M.
Zijlstra, Josée
Chamuleau, Martine
Lugtenburg, Pieternella
José Kersten, Marie
Dinmohamed, Avinash
P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
title P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
title_full P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
title_fullStr P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
title_full_unstemmed P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
title_short P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
title_sort p1139: comparison of 6xr-chop21 versus 6xr-chop+2r for advanced-stage diffuse large b-cell lymphoma: a propensity score weighted population-based analysis
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431182/
http://dx.doi.org/10.1097/01.HS9.0000971452.80376.cd
work_keys_str_mv AT maascarolien p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis
AT vanklaverendavid p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis
AT durmazmujde p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis
AT visserotto p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis
AT issadjamila p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis
AT posthumaeduardusfm p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis
AT zijlstrajosee p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis
AT chamuleaumartine p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis
AT lugtenburgpieternella p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis
AT josekerstenmarie p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis
AT dinmohamedavinash p1139comparisonof6xrchop21versus6xrchop2rforadvancedstagediffuselargebcelllymphomaapropensityscoreweightedpopulationbasedanalysis